These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 16802362)

  • 1. Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids.
    Shah B; Kakumanu VK; Bansal AK
    J Pharm Sci; 2006 Aug; 95(8):1641-65. PubMed ID: 16802362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of pharmaceutically relevant materials at the solid state employing chemometrics methods.
    Calvo NL; Maggio RM; Kaufman TS
    J Pharm Biomed Anal; 2018 Jan; 147():538-564. PubMed ID: 28666554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic vapor sorption as a tool for characterization and quantification of amorphous content in predominantly crystalline materials.
    Sheokand S; Modi SR; Bansal AK
    J Pharm Sci; 2014 Nov; 103(11):3364-3376. PubMed ID: 25213429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy.
    Heinz A; Strachan CJ; Gordon KC; Rades T
    J Pharm Pharmacol; 2009 Aug; 61(8):971-88. PubMed ID: 19703341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in the quantitative analytical methods of drug polymorphism].
    Ma LW; Du W; Zhao CS
    Yao Xue Xue Bao; 2011 Aug; 46(8):896-903. PubMed ID: 22007512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns.
    Bates S; Zografi G; Engers D; Morris K; Crowley K; Newman A
    Pharm Res; 2006 Oct; 23(10):2333-49. PubMed ID: 17021963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal polymorphism in chemical process development.
    Lee AY; Erdemir D; Myerson AS
    Annu Rev Chem Biomol Eng; 2011; 2():259-80. PubMed ID: 22432619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemometrics-assisted solid-state characterization of pharmaceutically relevant materials. Polymorphic substances.
    Calvo NL; Maggio RM; Kaufman TS
    J Pharm Biomed Anal; 2018 Jan; 147():518-537. PubMed ID: 28668295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of mid-IR spectroscopy for the characterization of pharmaceutical systems.
    Van Eerdenbrugh B; Taylor LS
    Int J Pharm; 2011 Sep; 417(1-2):3-16. PubMed ID: 21167267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the crystalline and amorphous states of drug products by nanothermal analysis and Raman imaging.
    Nakamoto K; Urasaki T; Hondo S; Murahashi N; Yonemochi E; Terada K
    J Pharm Biomed Anal; 2013 Mar; 75():105-11. PubMed ID: 23246930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Simple method for quantitative determination of active polymorphous and amorphous drugs in drug products by fourier transform-Raman spectroscopy].
    Ueno T; Urakami K; Higashi A; Umemoto K; Godo M; Kitamura K
    Yakugaku Zasshi; 2005 Oct; 125(10):807-14. PubMed ID: 16205038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of recent studies on the analysis of pharmaceutical polymorphs.
    Chieng N; Rades T; Aaltonen J
    J Pharm Biomed Anal; 2011 Jun; 55(4):618-44. PubMed ID: 21237609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-state NMR in the analysis of drugs and naturally occurring materials.
    Paradowska K; Wawer I
    J Pharm Biomed Anal; 2014 May; 93():27-42. PubMed ID: 24173236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The solid-state continuum: a perspective on the interrelationships between different solid-state forms in drug substance and drug product.
    Elder DP; Patterson JE; Holm R
    J Pharm Pharmacol; 2015 Jun; 67(6):757-72. PubMed ID: 25124049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermodynamics of water-solid interactions in crystalline and amorphous pharmaceutical materials.
    Sacchetti M
    J Pharm Sci; 2014 Sep; 103(9):2772-2783. PubMed ID: 24327540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of net analyte signal (NAS) in near infrared spectroscopy pharmaceutical applications: interpretability and figures of merit.
    Sarraguça MC; Lopes JA
    Anal Chim Acta; 2009 May; 642(1-2):179-85. PubMed ID: 19427474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.
    Murdande SB; Pikal MJ; Shanker RM; Bogner RH
    J Pharm Sci; 2010 Mar; 99(3):1254-64. PubMed ID: 19697391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical solvates, hydrates and amorphous forms: A special emphasis on cocrystals.
    Healy AM; Worku ZA; Kumar D; Madi AM
    Adv Drug Deliv Rev; 2017 Aug; 117():25-46. PubMed ID: 28342786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of residual crystallinity in ball milled commercially sourced lactose monohydrate by thermo-analytical techniques and terahertz spectroscopy.
    Smith G; Hussain A; Bukhari NI; Ermolina I
    Eur J Pharm Biopharm; 2015 May; 92():180-91. PubMed ID: 25784570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.